MAIN INDICATIONS

MD-TISSUE is a medical device designed to improve movement and to reduce associated pain, counteracting physiological or pathological deterioration of the soft tissues that constitute the extra-articular support system, such as: tendons, ligaments, joint capsule.

Scientific evidence shows the efficacy and safety of MD-TISSUE:
• in the treatment of tendinopathies (epicondylitis, Achilles’ tendonitis, supraspinatus tendonitis)
• in the treatment of connective tissue disorders (plantar fasciitis)
• in the treatment of scars and wounds.

Treatment can be combined with other therapies.

THERAPEUTIC PROTOCOL:

1-2 infiltrations per week to contain physiological deterioration of the soft tissues (tendons, ligaments, joint capsule).
Results are evident from the third week but, depending on the patient's clinical situation, it is possible to continue treatment up to the tenth week without risk.

COMPOSITION

Collagen of porcine origin, Ascorbic acid, Magnesium gluconate, Pyridoxine hydrochloride, Riboflavin, Thiamine hydrochloride, NaCl, Water for injection.

PACKAGE
Box of 10 vials (single vial 2 ml – extraction volume).

INJECTION ROUTES OF ADMINISTRATION
Periarticular or peritendinous, intradermal.

SUGGESTED NEEDLES
• Periarticular: 26G x 13 mm needle.
• Intradermal: 4-6 mm needle.
Note: Disinfect the skin thoroughly with iodopovidone or chlorhexidine.

INJECTION TECHNIQUES OF ADMINISTRATION

• Periarticular administration: insert the needle perpendicular to the skin plane at the required depth. Make multiple microinjections of 0.3 - 0.5 ml each.
• Intradermal administration: insert the needle to a depth of 4-6 mm. Make microinjections of 0.2 - 0.3 ml into the tissue to be treated.